Article Information
History
- August 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Giorgio Gaglia1,2,3,*,
- Megan L. Burger4,5,*,
- Cecily C. Ritch1,2,3,
- Danae Rammos1,2,3,
- Yang Dai1,2,3,
- Grace E. Crossland4,
- Sara Z. Tavana4,
- Simon Warchol6,
- Alex M. Jaeger4,
- Santiago Naranjo4,5,
- Shannon Coy1,2,3,
- Ajit J. Nirmal1,7,
- Robert Krueger1,6,
- Jia-Ren Lin1,2,
- Hanspeter Pfister6,
- Peter K Sorger1,2,8,#,
- Tyler Jacks4,5,# and
- Sandro Santagata1,2,3,8,#,†
- 1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA
- 2Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA
- 3Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
- 4David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- 5Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- 6School of Engineering and Applied Sciences, Harvard University, Boston, MA 02134, USA
- 7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
- 8Department of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA
- ↵†Lead contact: Sandro Santagata, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, Massachusetts 02115. Phone: 617-525-5686; E-Mail: ssantagata{at}bics.bwh.harvard.edu